Press Release RC INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that Ready Capital Corporation Investors with Substantial Losses Have Opportunity to Lead the Ready Capital Class Action Lawsuit 8 March 2025
Press Release Q32 Bio Presents Results from SIGNAL-AA Part A Clinical Trial Evaluating Bempikibart in Patients with Alopecia Areata at the 2025 American Academy of Dermatology Meeting 8 March 2025
Press Release LEO Pharma Presents New Late-Breaking Delgocitinib Cream Data For the Third Consecutive Year at AAD 2025 8 March 2025
Press Release Incyte Announces Results of Phase 3 Clinical Trials Evaluating Ruxolitinib Cream 1.5% (Opzelura®) in Patients with Prurigo Nodularis (PN) at 2025 American Academy of Dermatology Annual Meeting 8 March 2025
Press Release Bristol Myers Squibb Presents Late-Breaking Data from Phase 3 POETYK PsA-2 Trial Demonstrating Superiority of Sotyktu (deucravacitinib) Compared with Placebo in Adults with Psoriatic Arthritis 8 March 2025
Press Release New Analysis of Organon’s VTAMA® (tapinarof) cream, 1% Phase 3 Data Shows Atopic Dermatitis Disease Activity Remained Low After Treatment-Free Interval in Adults and Children 2 Years of Age and Older 8 March 2025
Data, Policy & Regulation The Trust Crisis: Why Data Governance Will Make or Break Our AI Future 8 March 2025
Digital Transformation, Environment & Sustainability Sustainable Power: Solving the energy challenges of AI 8 March 2025
